乳癌に対するS-1投与中に発症した鼻涙管閉塞例

書誌事項

タイトル別名
  • A Case of Nasolacrimal Duct Obstruction During S-1 Treatment For Breast Cancer
  • ニュウガン ニ タイスル S-1 トウヨ チュウ ニ ハッショウ シタ ハナ ルイカン ヘイソクレイ

この論文をさがす

抄録

<p>S-1, an oral 5-FU prodrug, is an antineoplastic agent used for the treatment of various types of cancer, including cancer of the head and neck. In addition to inflammation, infection, trauma, and iatrogenic causes, nasolacrimal duct obstruction could also be caused by S-1. Herein, we report the case of a patient with nasolacrimal duct obstruction that was suspected to be caused by S-1, and was successfully treated by endoscopic dacryocystorhinostomy (DCR). The patient, a 69-year-old woman, was initiated on treatment with S-1 as adjuvant therapy after resection of breast cancer. Four months later, she developed epiphora, and the lacrimal ducts were intubated with silicone tubes. A year later, she presented with recurrence of epiphora, and was referred to our department. We performed right DCR for nasolacrimal duct obstruction, and the epiphora improved. Although the mechanism of nasolacrimal duct obstruction caused by S-1 has not yet been clarified, otorhinolaryngologists should be aware of this condition.</p>

収録刊行物

参考文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ